Home » Reports » Broker Ratings » AstraZeneca plc 15.5% Potential Upside Indicated by JP Morgan Cazenove
broker ratings

AstraZeneca plc 15.5% Potential Upside Indicated by JP Morgan Cazenove

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ today by analysts at JP Morgan Cazenove. AstraZeneca plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set their target price at 5500 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 15.5% from the opening price of 4760 GBX. Over the last 30 and 90 trading days the company share price has decreased 393 points and decreased 274 points respectively. The 52 week high share price is 5520 GBX while the 52 week low for the stock is 4260 GBX.

AstraZeneca plc has a 50 day moving average of 5,011.77 GBX and a 200 Day Moving Average share price is recorded at 5,012.39. There are currently 1,267,122,978 shares in issue with the average daily volume traded being 1,863,396. Market capitalisation for LON:AZN is £60,673,647,081 GBP.